Albert Assad MD

Otolaryngology (ENT)•New Brunswick, NJ

Neurotology

Physician

Join to View Full Profile

254 Easton AveNew Brunswick, NJ 08901
Phone+1 732-745-8571
Fax+1 732-249-5284

Education & Training

Plastic SurgeryFellowship, Plastic Surgery, 2013 - 2013
Massachusetts Institute of Technology - Sloan School of ManagementMasters of Science, Management, 2006 - 2009
Mass General Brigham/Massachusetts Eye and Ear/Harvard Medical SchoolResidency, Otolaryngology - Head and Neck Surgery, 1994 - 1999
Mass General Brigham/Massachusetts Eye and Ear/Harvard Medical SchoolFellowship, Neurotology, 1995 - 1996
Beth Israel Deaconess Medical CenterInternship, Surgery, 1993 - 1994
Yale School of MedicineClass of 1993

Certifications & Licensure

MA State Medical License 1995 - 2026
NY State Medical License 2013 - 2026
NJ State Medical License 2003 - 2023
IL State Medical License 2000 - 2005

Awards, Honors, & Recognition

Meriorious Service Medal US Air Force, 2015
Fellow International College of Surgeons, 2000

Clinical Trials

Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Ischemic Stroke Start of enrollment: 2011 Mar 01
Terminated
Phase 2
A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis Start of enrollment: 2017 Feb 08
Terminated
Phase 2
Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272) Start of enrollment: 2017 Nov 14
Terminated
Phase 2
An Open Label Study of Itacitinib Administered Orally in Patients With Myelofibrosis Start of enrollment: 2012 Jul 16
Completed
Phase 2
Study to Determine the Safety and Efficacy of INCB018424 in Patients With Polycythemia Vera or Essential Thrombocythemia Start of enrollment: 2008 Aug 20
Terminated
Phase 2
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia Start of enrollment: 2016 Sep 30
ACTIVE_NOT_RECRUITING
PHASE2
To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313) Start of enrollment: 2021 May 27
TERMINATED
PHASE3
To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304) Start of enrollment: 2021 May 26
TERMINATED
PHASE3
Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors Start of enrollment: 2013 Jun 01
Completed
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

5 citations
Digital image analysis of optic nerve head pallor as a diagnostic test for early glaucoma
Albert Assad, Joseph Caprioli
Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 1992-01-01